This website uses cookies. By continuing to use this website, you consent to our use of these cookies.
You can find out more about how we use cookies and how to manage them by reading our Privacy Policy
Close [X]

The reasons
for choosing
Suplasyn 1-Shot
Go to
Video Gallery

Advantages of only 1 injection

  • Time savingTime saving (3)
  • Patient compilancePatient Compliance (1)
  • Reduction of riskReduction of risk of post-injection infection (3)
  • Reduction of the costReduction of the cost of treatment (1,3)

6 month patient relief Up to 6 month significant
pain relief
and improvement
of functionality (1)

Very good safety profile Very good safety profile

Intended for single administration Intended for single administration.

Up to 6 month significant pain relief
and improvement of functionality (1)

Results after 1 injection of suplasyn® 1-shot only at month 3 and 6
Significant improvement in functionallity:+34.9%*
Lequesne index score
Results table 01
V1
V3
Month 3
V4
Month 6


The Lesquene index measured at 3 and 6 months after a Suyplasyn® 1-Shot injection was significant lower than the baseline score

Relevant decrease in VAS pain scores
-39.9%*
at rest
-37.8%*
Walking
mm (EVA)
Results table 02
VAS at rest
VAS walking
Baseline
Month 3
Month 6

* Month 6 vs Baseline
Significant decrease in pain scores determined from the VAS as measured by the patient at 3 and 6 months after Suplasyn® 1-Shot injection

Very good safety profile

98% No adverse events (3)

Suplasyn® 1-shot has shown less 2.2% adverse events than referenced by high MW HA in other studies (2)

Patient satisfaction at month 3 (1)
  • 86.7% of patients declared an
    improvement in their health
Patient satisfaction at month 6 (1)
  • 88% of patients would repeat the
    treatment with Suplasyn® 1-Shot
  • SUPLASYN® 1-Shot is intended to be a single administration (1)
  • Up to 6 MONTH clinical effect on pain and functionality (1) *
  • OPTIMUM MOLECULAR Weight: optimum stimulation of endogenous Hyaluronic
    Acid synthesis & increased access to diseased tissue (4)
  • EASY for doctors to inject (low viscosity)
  • Very good SAFETY (1,2)
At least 6 months

1. Blanch J et al. ASKOT STUDY: Effectiveness and safety of a 1-shot injection of sodium Hyaluronate for knee osteoarthritis treatment. Springer Experience & Drug Evidence.
2. Chevalier X. et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis 2010;69:113–119.
3. D. Van Linthoudt and U.E. Gasser. Evaluation of the analgesic efficacy and short-term tolerance of a single 6 ml injection of hyaluronic acid (Suplasyn® 1-Shot) on osteoarthritis of the knee. Dolor. 2013;28:89-92.
4. Vitanzo C et al. Hyaluronans: Is clinical effectiveness dependent on molecular weight?The American Journal of Orthopedics. 2006; 421-28.

* This depends on patient's individual response

Suitable for larger
synovial joints
Injection techniques
close
close
close
close